GlassScriptPhysician profile
Sara G Rinala
NPI 1861651176
$1,206.51
in general payments reported to CMS, 2019-2025
22 companies · $218 in 2025
The $218 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $207 · 2020: $34.61 · 2022: $303 · 2023: $160 · 2024: $283 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $563 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $562.59 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $212.73 | 2023-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $119.56 | 2022-2025 | |
| Coopersurgical, INC. | $97.04 | 2019-2025 | Paragard T 380a |
| Abbvie INC. | $94.49 | 2019-2024 | Liletta |
| Aspira Women'S Health INC | $88.15 | 2022 | |
| Gynesonics, INC. | $83.46 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Pfizer INC. | $67.65 | 2024-2025 | |
| Sage Therapeutics, LLC | $62.69 | 2024-2025 | Zurzuvae |
| Merck Sharp & Dohme LLC | $51.99 | 2019-2024 | Gardasil 9, Gardasil |
| Exeltis, USA INC. | $50.54 | 2019-2023 | Slynd |
| Therapeuticsmd, INC. | $46.52 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.32 | 2020-2022 | |
| Sumitomo Pharma America, INC. | $31.27 | 2024 | Myfembree |
| Amag Pharmaceuticals, INC. | $27.75 | 2019-2020 | |
| Avion Pharmaceuticals | $25.37 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $21.22 | 2019 | |
| Organon LLC | $20.77 | 2022-2025 | Nexplanon |
| Shield Therapeutics INC | $19.94 | 2023 | Accrufer |
| Ethicon US, LLC | $17.60 | 2025 | Vistaseal, Surgicel Nu-Knit, Stratafix |
| Ascend Therapeutics US, LLC | $14.42 | 2019 | |
| Vertical Pharmaceuticals, LLC | $11.34 | 2019 | |
| Daiichi Sankyo INC. | $10.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Rinala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.